Phase II Study of Trastuzumab Rezetecan or in Combination With Adebrelimab in HER2-Expressing Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC)
PHASE2
This is a multicenter, open-label, Phase II clinical trial to evaluate the ...
Status
Recruiting
Location
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
A Clinical Study of Disitamab Vedotin for Injection Combined With Penpulimab Injection in Neoadjuvant Therapy for Patients With HER2-expressing Cisplatin-intolerant cT2-T4aNxM0 Bladder Urothelial Carcinoma
PHASE4
This study is a one-arm exploratory clinical study of Disitamab Vedotin for...
To Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravesical Instiliations of Disitamab Vedotin in Patients With High-risk Non-muscular Invasive Bladder Cancer (NMIBC) That Express HER2
PHASE1
The purpose of this study is to evaluate the safety, efficacy, and pharmaco...
Status
Recruiting
Location
Sun Yat-sen Memorial Hospital,SunYat-sen University